|
Company Watch
Avesthagen and Manipal Acunova join hands
Our News Bureau - Mumbai
Avestha
Gengraine Technologies has signed an MOU with Manipal Acunova (a collaborative
venture between the Manipal Education and Medical Group International India,
and AcuNova Life Sciences). This partnership will enable the two companies to
jointly provide a fully integrated platform from early discovery to filing approvals
for new products. This will enable the companies to screen candidates and move
the promising ones to the market faster.
Avesthagen and Manipal Acunova will collaborate on providing their competencies
in discovery, pre-clinical, clinical research including regulatory matters.
The companies will also collaborate in the validation of molecular diagnostic
kits and product co-development for delivering high quality, affordable and
advanced diagnostic tests using molecular techniques; to patients and the healthcare
industry. They will also jointly apply and own the Intellectual Property rights
to the database or samples or process or products that are created during the
agreement. "The collaboration will bring in a range of services to the
clients expanding to biogenerics, bio-nutraceuticals and biopharma companies,"
said D A Prasanna, Founder and Vice-Chairman of Manipal Acunova.
In yet another development, New York Life Investment Management India Fund (NYLIM
India Fund-based in Mauritius) has invested around Rs 225 million in share capital
in Avesthagen through equity shares for a minority stake. Avesthagen will apply
the investment towards the expansion of its business and to increase its international
presence.
Avesthagen expects to commercially launch some of its products for the biopharma
and bio-nutritional markets in 2008. The company is also planning to ramp up
its headcount to over 600 within the next 12 months. "Avesthagen will continue
to enhance stakeholder value while offering the current and future employees
a tremendous opportunity to be part of exciting growth and the making of a global
blue-chip enterprise," said Dr Villoo Morawala Patell, Vice-Chairperson,
Founder CEO, Avesthagen .
|